Therapix Biosciences (Israel) Probability of Target Price Finishing Over Current Price

TRPX -- Israel Stock  

null 33.70  0.70  2.12%

Therapix Biosciences probability of target price tool provides mechanism to make assumptions about upside and downside potential of Therapix Biosciences Ltd performance during a given time horizon utilizing its historical volatility. Please specify Therapix Biosciences time horizon, a valid symbol (red box) and a target price (blue box) you would like Therapix Biosciences odds to be computed. Also please take a look at World Market Map.
Horizon     30 Days    Login   to change
Refresh Odds

Therapix Biosciences Target Price Odds to finish over

Current PriceHorizonTarget PriceOdds to move above current price in 30 days
 33.70 30 days 33.70  ABOUT 26.79%
Based on normal probability distribution, the odds of Therapix Biosciences to move above current price in 30 days from now is about 26.79% (This Therapix Biosciences Ltd probability density function shows the probability of Therapix Biosciences Stock to fall within a particular range of prices over 30 days) .
Assuming 30 trading days horizon, Therapix Biosciences Ltd has beta of -0.6539 . This entails as returns on benchmark increase, returns on holding Therapix Biosciences are expected to decrease at a much smaller rate. During bear market, however, Therapix Biosciences Ltd is likely to outperform the market. Additionally The company has an alpha of 0.0207 implying that it can potentially generate 0.0207% excess return over DOW after adjusting for the inherited market risk (beta).
 Therapix Biosciences Price Density 
Alpha over DOW
Beta against DOW=0.65
Overall volatility
Information ratio =0.03

Therapix Biosciences Alerts and Suggestions

Therapix Biosciences is not yet fully synchronised with the market data
Therapix Biosciences has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of . Net Loss for the year was (7.66M).
THERAPIX BIO has accumulated about 7.51M in cash with (6.01M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.